Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/23/22 17:10 | 6/21/22 | ACLX | Health | BioPrd | Biological Products, (No Diag | New Enterprise Associates 15, L.P. | MD | T | P | 5,000 | 16.00 | 0 | 313 | 5 | 6,745 | D | |||||||||||||||
2/10/22 08:41 | 2/8/22 | ACLX | Health | BioPrd | Biological Products, (No Diag | Sr One Capital Management, LLC | PA | T | P.d | 25,000 | 15.00 | 0 | 1,667 | 455 | 2,033 | I | |||||||||||||||
2/9/22 18:18 | 2/8/22 | ACLX | Health | BioPrd | Biological Products, (No Diag | New Enterprise Associates 15, L.P. | MD | T | P.d | 23,750 | 15.00 | 0 | 1,583 | 33 | 6,433 | D | |||||||||||||||
2/9/22 17:51 | 2/8/22 | ACLX | Health | BioPrd | Biological Products, (No Diag | Carroll Jill | MD | D | P.d | 25,000 | 15.00 | 0 | 1,667 | 455 | 2,033 | I | |||||||||||||||
2/9/22 17:42 | 2/8/22 | ACLX | Health | BioPrd | Biological Products, (No Diag | Novo Holdings A/s | G7 | T | P.d | 12,500 | 15.00 | 0 | 833 | 26 | 4,017 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |